MRK.DEライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (29 4月 2024 @ 21:40):

Stats
本日の出来高	45 487.00
平均出来高	282 181
時価総額	64.68B
EPS	€0 ( 2024-03-06 )
次の収益日	( €1.980 ) 2024-05-15
Last Dividend	€2.20 ( 2023-05-02 )
Next Dividend	€0 ( N/A )
P/E	23.04
ATR14	€0.0800 (0.05%)

ボリューム相関

長: -0.01 (neutral)

短: -0.61 (weak negative)

Signal:(43.203) Neutral

Merck KGaA 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Merck KGaA 相関 - 通貨/商品

-0.12
( neutral )

0.33
( neutral )

0.00
( neutral )

-0.52
( weak negative )

-0.21
( neutral )

-0.04
( neutral )

Merck KGaA 財務諸表

Annual	2023
収益:	€20.99B
総利益:	€11.67B (55.59 %)
EPS:	€6.50

FY	2023
収益:	€20.99B
総利益:	€11.67B (55.59 %)
EPS:	€6.50

FY	2022
収益:	€22.23B
総利益:	€13.71B (61.65 %)
EPS:	€7.65

FY	2021
収益:	€19.69B
総利益:	€12.34B (62.66 %)
EPS:	€7.03

Financial Reports:

No articles found.

Merck KGaA Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€0 (N/A)	€2.20 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Merck KGaA Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.41 - Stable (8.28%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.418	2000-05-12
Last Dividend	€2.20	2023-05-02
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	25	--
Total Paid Out	€22.03	--
Avg. Dividend % Per Year	0.00%	--
Score	3.43	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.41
Div. Directional Score	8.93	--

Next Divdend (Est)
(2025-03-31)

€2.36 Estimate 3.12 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.43

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
HNR1.DE	Ex Dividend Junior	2023-05-04	Annually	0.00%
SDF.DE	Ex Dividend Junior	2023-05-11	Annually	0.00%
CEK.DE	No Dividend Player	2023-11-06	Sporadic	0.00%
KRN.DE	Ex Dividend Knight	2023-05-24	Annually	0.00%
TTK.DE	Ex Dividend Junior	2023-05-25	Annually	0.00%
DWD.DE	Ex Dividend Junior	2023-07-28	Quarterly	0.00%
MZX.DE	Ex Dividend Knight	2023-06-08	Sporadic	0.00%
8TRA.DE	Ex Dividend Junior	2023-06-02	Annually	0.00%
XGR2.DE	Ex Dividend Junior	2023-06-08	Annually	0.00%
FPMB.DE	Ex Dividend King	2023-10-12	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.135	1.500	7.31	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0575	1.200	8.08	9.70	[0 - 0.3]
returnOnEquityTTM	0.105	1.500	9.95	10.00	[0.1 - 1]
payoutRatioTTM	0.440	-1.000	5.60	-5.60	[0 - 1]
currentRatioTTM	1.425	0.800	7.88	6.30	[1 - 3]
quickRatioTTM	0.822	0.800	9.87	7.90	[0.8 - 2.5]
cashRatioTTM	0.228	1.500	9.85	10.00	[0.2 - 2]
debtRatioTTM	0.194	-1.500	6.76	-10.00	[0 - 0.6]
interestCoverageTTM	11.33	1.000	6.92	6.92	[3 - 30]
operatingCashFlowPerShareTTM	8.70	2.00	7.10	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.52	2.00	7.74	10.00	[0 - 20]
debtEquityRatioTTM	0.358	-1.500	8.57	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.590	1.000	3.50	3.50	[0.2 - 0.8]
operatingProfitMarginTTM	0.182	1.000	8.36	8.36	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.396	1.000	8.91	8.91	[0.2 - 2]
assetTurnoverTTM	0.427	0.800	-0.484	-0.387	[0.5 - 2]
Total Score				12.44

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	23.35	1.000	7.74	0	[1 - 100]
returnOnEquityTTM	0.105	2.50	9.97	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.52	2.00	8.49	10.00	[0 - 30]
dividendYielPercentageTTM	2.90	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.70	2.00	7.10	10.00	[0 - 30]
payoutRatioTTM	0.440	1.500	5.60	-5.60	[0 - 1]
pegRatioTTM	-9.98	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.180	1.000	7.99	0	[0.1 - 0.5]
Total Score				5.41

Merck KGaA

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.